Herpes simplex virus-mediated gene delivery to the rodent visual system

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1392-1401

  Spencer, Brian ^a   Agarwala, Seema ^a   Miskulin, Michael ^a   Smith, Morton ^a   Brandt, Curtis R ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HERPES SIMPLEX VIRUS; LATERAL GENICULATE NUCLEUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA DETACHMENT; VISUAL CORTEX; VISUAL NERVOUS SYSTEM;

ANIMALS; BETA-GALACTOSIDASE; CERCOPITHECUS AETHIOPS; CORNEA; DEFECTIVE VIRUSES; EYE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; IMMUNOENZYME TECHNIQUES; LAC OPERON; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDE REDUCTASES; VERO CELLS; VISUAL CORTEX; VITREOUS BODY;

EID: 0034112841     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Bennet J, Pakola S, Zeng Y, Maguire A. Humoral response after administration of E1-deleted adenovirus: immune privilege of the subretinal space. Hum Gene Ther. 1996;7:1763-1769.
2. Bennet J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediates in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci. 1994;35:2535-2542.
3. Li T, Adamian M, Roof DJ, et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci. 1994;35:2545-2549.
4. Hoffman LM, Maguire AM, Bennett J. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci. 1997;38: 2224-2233.
5. Jomary C, Piper TA, Dickson G, et al. Adenovirus-mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett. 1994;347:117-122.
6. Mashhour B, Couton D, Perricaudet M, Briand P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther. 1994;1: 122-126.
7. Budenz DL, Bennet J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1995;36:2211-2215.
8. Borras T, Tamm ER, Samuel Zigler J. Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthalmol Vis Sci. 1996;37:1282-1293.
9. Cayouette M, Gravel C. Adenovirus-mediated gene transfer to retinal ganglion cells. Invest Opbthalmol Vis Sci. 1996;37:2022-2028.
10. Abraham NG, Silva J-L, Lavrovsky Y, et al. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci. 1995;36:2202-2210.
11. Akimoto M, Miyatake S-I, Kogishi J-I, et al. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rat. Invest Ophthalmol Vis Sci. 1999;40:273-279.
12. Cayouette M, Gravel C. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther. 1997;8: 423-430.
13. Lewin AS, Drenser KA, Hauswirth WW, et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med. 1998;4:967-971.
14. Li T, Davidson BL. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc Natl Acad Sci USA. 1995;92:7700-7704.
15. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1994;1: 433-442.
16. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA. 1994;91:4407-4411.
17. Dai Y, Schwarz EM, Gu D, et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA. 1995;92:1401-1405.
18. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-227.
19. Borras T, Matsumoto Y, Epstein DL, Johnson DH. Gene transfer to the human trabecular meshwork by anterior segment perfusion. Invest Ophthalmol Vis Sci. 1998;39:1503-1507.
20. Ali RR, Reichel MB, Thrasher AJ, et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet. 1996;5:591-594.
21. Grant CA, Ponnazhagan S, Wang X-S, Srivastava A, Li T. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Curr Eye Res. 1997:949-956.
22. Flannery JG, Zolotukhin S, Vaqeuro MI, et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA. 1997;94:6916-6921.
23. Bennet J, Duan D, Engethardt JF, Maguire AM. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci. 1997;38:2857-2863.
24. Guy J, Qi X, Hauswirth WW. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc Natl Acad Sci USA. 1998;95:13847-13852.
25. Bradshaw JJ, Obritsch WF, Cho B-J, Gregerson DS, Holland EJ. Ex vivo transduction of corneal epithelial progenitor cells using a retroviral vector. Invest Ophthalmol Vis Sci. 1999;40:230-235.
26. Seitz B, Moreira L, Baktanian E, et al. Retroviral vector-mediated gene transfer into keratocytes in vitro and in vivo. Am J Ophthalmol. 1998;126:630-639.
27. Sakamoto T, Kimura H, Scuric Z, et al. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Ophthalmology. 1995;102:1417-1424.
28. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72:8150-8157.
29. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA. 1997;94:10319-10323.
30. Johnson PA, Miyanohara A, Levine F, Cahill T, Friedmann T. Cytotoxicity of a replication-defective mutant of Herpes simplex virus type 1. J Virol. 1992;66:2952-2965.
31. Wu N, Watkin SC, Schaffer PA, DeLuca NA. Prolonged gene expression and cell survival after infection by a Herpes simplex virus mutant defective in the immediate early genes encoding ICP4, ICP27 and ICP22. J Virol. 1996;70:6358-6369.
32. Dobson AT, Margolis TP, Sedarati F, Stevens JG, Feldman LT. A latent, nonpathogenic HSV-1 derived vector stably expresses β-galactosidase in mouse neurons. Neuron. 1990;5:353-360.
33. Huard J, Akkaraju G, Watkins SC, Pike-Cavalcoli M, Glorioso JC. Lac Z gene transfer to skeletal muscle using a replication-defective Herpes simplex virus type 1 mutant vector. Hum Gene Ther. 1997;8:439-452.
34. Fraefel C, Song S, Lim F, et al. Helper virus-free transfer of Herpes simplex virus type 1 plasmid vectors into neural cells. J Virol. 1996;70:7190-7197.
35. Fink DJ, DeLuca NA, Goins Wf, Glorioso JC. Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci. 1996;19:265-287.
36. Wood MJA, Byrnes AP, Pfaff DW, Rabkin SD, Charlton HM. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1994;1:283-291.
37. Chiocca EA, Choi BB, Cai W, et al. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus insertion mutants. New Biologist. 1990;2:739-746.
38. Fink DJ, Sternberg LR, Weber PC. et al. In vivo expression of β-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther. 1992;3:11-19.
39. 1 34.5 mutant of Herpes simplex 1 causes severe inflammation in the brain. Neuroscience. 1998;83:1225-1237.
40. Thelander L, Reichard P. Reduction of ribonucleotides. Annu Rev Biochem. 1979;48:133-158.
41. Goldstein DJ, Weller SK. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J Virol. 1988;62:196-205.
42. Goldstein DJ, Weller SK Factor(s) present in Herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology. 1988;166:41-51.
43. Brandt CR, Untawale S, Elliasse-Rad B, et al. The Herpes simplex virus type 1 ribonucleotide reductase is required for acute retinal infection. Arch Virol. 1997;142:883-896.
44. Yamada Y, Kimura H, Morishima T, et al. The pathogenicity of ribonucleotide reductase (RR): null mutants of Herpes simplex virus type 1 in mice. J Infect Dis. 1991;164:1091-1097.
45. Brandt CR, Kintner RL, Pumfrey AM, Visalli RJ, Grau DR. The Herpes simplex virus ribonucleotide reductase is required for ocular virulence. J Gen Virol. 1991;72:2043-2049.
46. Cameron JM, McDougall I, Marsden HS, et al. Ribonucleotide reductase encoded by Herpes simplex virus is a determinant of pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol. 1988;69:2607-2612.
47. Idowu AD, Fraser-Smith EB, Poffenberger KL, Herman RC. Deletion of the Herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo. Antiviral Res. 1992;17: 145-156.
48. Jacobsen JG, Leib DA, Goldstein DJ, et al. A Herpes simplex virus ribonucleotide reductase deletion mutant is defective for acute and reactivatable latent infections of mice and for replication in mouse cells. Virology. 1989;173:276-283.
49. Grau DR, Visalli RJ, Brandt CR. Herpes simplex virus stromal keratitis is not liter-dependent and does not correlate with neurovirulence. Invest Ophthalmol Vis Sci. 1989;30:2474-2480.
50. Visalli RJ, Brandt CR. The HSV-1 UL45 18 kDa gene product is a true late protein and a component of the virion. Virus Res. 1993; 29:167-178.
51. Liu X, Brandt CR, Gabelt BT, et al. Herpes simples virus mediated gene transfer to primate ocular tissues. Exp Eye Res. 1999;69:385-395.
52. Paxinos G, Watson C, Pennisi M, Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods. 1985;13:139-143.
53. Rosenberg WS, Breakfield XO, DeAntonio C, Isacson O. Authentic and artifactual detection of the E. coli lacZ gene product in the rat brain by histochemical methods. Mol Brain Res. 1992;16:311-315.
54. Agarwala S, Kalil RE. Axotomy-induced neuronal death and reactive astroglia in the lateral geniculate nucleus following a lesion of the visual cortex in the rat. J Comp Virol. 1998;392:252-263.
55. Bennet J, Tanabe T, Sun D, et al. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med. 1996;2:649-654.
56. Masuda I, Matsuo T, Yasuda T, Matsuo N. Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci. 1996;37:1914-1920.
57. Huang Q, Vonsattel J-P, Schaffer PA, et al. Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using Herpes simplex virus mutants: a light and electron microscopic study. Exp Neurol. 1992;115:303-316.
58. Song S, Wang Y, Bak S-Y, et al. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem. 1997;68: 1792-1803.
59. McLean JH, Shipley MT, Berstein DI. Golgi-like transneuronal retrograde labeling in CNS injections of herpes simplex virus type-1. Brain Res Bull. 1989;22:867-881.
60. Norgren RB, Lehman MN. Retrograde trans-neuronal transport of herpes simplex virus in the retina after injection in the superior colliculus, hypothalamus and optic chiasm. Brain Res. 1989;479:374-378.